(1S,2R)-2-((benzyloxy)carbonyl)cyclohexane-1-carboxylic acid, 98%, 500mg

2,5-Dibromo-3,6-dihydroxycyclohexa-2,5-diene-1,4-dione, 98%, 10g

Micropipeta monocanal mLINE® variable, 0,5 a 10 µl, 1 unidad

((2R,3S,4R,5R)-5-(3-Carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphate, 95.0%, 10g

(S)-2-amino-3-(3,4-dimethylphenyl)propanoic acid, 95+%, 5g

8-Bromo-5,6-difluoro-2-methylquinoline, 95.0%, 1g

(5-Bromo-2-chlorophenyl)boronic acid, 95.0%, 100mg

4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1H-PYRAZOLE-3-CARBOXYLIC ACID, 95.0%, 5g

4-[3-(N,N-Dimethylamino)phenyl]-4-oxobutyric acid, 97.0%, 1g

3-(4-(Trifluoromethyl)phenyl)azetidine hydrochloride, 95%, 100mg

2,6-Dimethylpyridin-4-ylamine, 95.0%, 5g

3-Chloro-4-(trifluoromethyl)benzonitrile, 95.0%, 5g

(R)-1-Aminopropan-2-ol, 95.0%, 5g